United Therapeutics Corp insider trading
UTHRfinancial statementsForm 4 filings on EDGAR3,985 transactions since Nov 1, 2024
From August 4, 2026 to November 1, 2026, 0 insiders at United Therapeutics Corp bought $0 of stock in the open market, and 3 sold $335M. Officers and directors accounted for $0 of purchases and $335M of sales. The last reported transaction was an option exercise by Rothblatt Martine A on October 29, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through October 30, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $335MAug 4, 2026 – Nov 1, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
3,985 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Oct 29, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | option exerciseindirect | 9,500 | $117.76 | $1M | 333,943 | Oct 30, 2026 |
| Oct 29, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 53 | $590.43 | $31K | 333,890 | Oct 30, 2026 |
| Oct 29, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 1,104 | $591.90 | $653K | 332,786 | Oct 30, 2026 |
| Oct 29, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 1,563 | $592.97 | $927K | 331,223 | Oct 30, 2026 |
| Oct 29, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 1,540 | $593.88 | $915K | 329,683 | Oct 30, 2026 |
| Oct 29, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 1,248 | $594.89 | $742K | 328,435 | Oct 30, 2026 |
| Oct 29, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 1,678 | $595.88 | $1000K | 326,757 | Oct 30, 2026 |
| Oct 29, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 1,355 | $596.86 | $809K | 325,402 | Oct 30, 2026 |
| Oct 29, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 919 | $597.66 | $549K | 324,483 | Oct 30, 2026 |
| Oct 29, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 40 | $599.30 | $24K | 324,443 | Oct 30, 2026 |
| Oct 28, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | option exerciseindirect | 9,500 | $117.76 | $1M | 333,943 | Oct 29, 2026 |
| Oct 28, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 821 | $583.50 | $479K | 333,122 | Oct 29, 2026 |
| Oct 28, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 2,625 | $584.43 | $2M | 330,497 | Oct 29, 2026 |
| Oct 28, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 1,902 | $585.36 | $1M | 328,595 | Oct 29, 2026 |
| Oct 28, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 3,086 | $586.37 | $2M | 325,509 | Oct 29, 2026 |
| Oct 28, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 986 | $587.27 | $579K | 324,523 | Oct 29, 2026 |
| Oct 28, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 80 | $588.39 | $47K | 324,443 | Oct 29, 2026 |
| Oct 27, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | option exerciseindirect | 9,500 | $117.76 | $1M | 333,943 | Oct 28, 2026 |
| Oct 27, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 89 | $582.66 | $52K | 333,854 | Oct 28, 2026 |
| Oct 27, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 807 | $583.94 | $471K | 333,047 | Oct 28, 2026 |
| Oct 27, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 1,417 | $584.83 | $829K | 331,630 | Oct 28, 2026 |
| Oct 27, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 470 | $585.72 | $275K | 331,160 | Oct 28, 2026 |
| Oct 27, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 1,417 | $586.93 | $832K | 329,743 | Oct 28, 2026 |
| Oct 27, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 1,320 | $587.88 | $776K | 328,423 | Oct 28, 2026 |
| Oct 27, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 1,597 | $588.95 | $941K | 326,826 | Oct 28, 2026 |
| Oct 27, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 1,003 | $589.98 | $592K | 325,823 | Oct 28, 2026 |
| Oct 27, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 700 | $590.99 | $414K | 325,123 | Oct 28, 2026 |
| Oct 27, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 600 | $592.05 | $355K | 324,523 | Oct 28, 2026 |
| Oct 27, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 80 | $592.84 | $47K | 324,443 | Oct 28, 2026 |
| Oct 26, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | option exerciseindirect | 9,500 | $117.76 | $1M | 333,943 | Oct 27, 2026 |
| Oct 26, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 600 | $585.71 | $351K | 333,343 | Oct 27, 2026 |
| Oct 26, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 1,492 | $586.54 | $875K | 331,851 | Oct 27, 2026 |
| Oct 26, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 2,707 | $587.54 | $2M | 329,144 | Oct 27, 2026 |
| Oct 26, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 1,241 | $588.47 | $730K | 327,903 | Oct 27, 2026 |
| Oct 26, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 1,280 | $589.64 | $755K | 326,623 | Oct 27, 2026 |
| Oct 26, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 680 | $590.57 | $402K | 325,943 | Oct 27, 2026 |
| Oct 26, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 694 | $591.60 | $411K | 325,249 | Oct 27, 2026 |
| Oct 26, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 806 | $592.92 | $478K | 324,443 | Oct 27, 2026 |
| Oct 23, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | option exerciseindirect | 9,500 | $117.76 | $1M | 333,943 | Oct 26, 2026 |
| Oct 23, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 200 | $577.68 | $116K | 333,743 | Oct 26, 2026 |
| Oct 23, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 700 | $578.80 | $405K | 333,043 | Oct 26, 2026 |
| Oct 23, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 1,038 | $579.74 | $602K | 332,005 | Oct 26, 2026 |
| Oct 23, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 1,017 | $580.78 | $591K | 330,988 | Oct 26, 2026 |
| Oct 23, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 1,650 | $581.82 | $960K | 329,338 | Oct 26, 2026 |
| Oct 23, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 1,732 | $582.78 | $1M | 327,606 | Oct 26, 2026 |
| Oct 23, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 427 | $583.83 | $249K | 327,179 | Oct 26, 2026 |
| Oct 23, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 676 | $584.77 | $395K | 326,503 | Oct 26, 2026 |
| Oct 23, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 778 | $585.99 | $456K | 325,725 | Oct 26, 2026 |
| Oct 23, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 542 | $586.93 | $318K | 325,183 | Oct 26, 2026 |
| Oct 23, 2026 | Rothblatt Martine A | Chairperson & CEO, Director | open-market sale10b5-1indirect | 740 | $588.00 | $435K | 324,443 | Oct 26, 2026 |
Who the insiders are
Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Rothblatt Martine A | Chairperson & CEO, Director | Oct 29, 2026 | option exercise | 42,231 | $864K (1) | $944M (2075) | 2075 of 2075 |
| Edgemond James | CFO AND TREASURER | Jun 22, 2026 | option exercise | 27,626 | — | $217M (402) | 402 of 402 |
| Benkowitz Michael | PRESIDENT AND COO | Mar 15, 2026 | option exercise | — | — | $178M (138) | 138 of 138 |
| Mahon Paul A | EVP & GENERAL COUNSEL | Oct 15, 2026 | option exercise | 53,472 | — | $109M (194) | 194 of 194 |
| Sullivan Louis W | Director | Jul 9, 2026 | option exercise | 2,983 | — | $3M (2) | 0 of 2 |
| Patusky Christopher | Director | Jul 9, 2026 | option exercise | 2,140 | — | $3M (3) | 2 of 3 |
| Thompson Tommy G | Director | Mar 26, 2026 | open-market sale | 8,480 | — | $3M (5) | 0 of 5 |
| Kurzweil Ray | Director | Jul 9, 2026 | option exercise | 13,320 | — | $2M (1) | 0 of 1 |
| Causey Christopher | Director | Mar 30, 2026 | option exercise | 5,490 | — | $2M (5) | 5 of 5 |
| Olian Judy D. | Director | Jul 9, 2026 | option exercise | 5,555 | — | $417K (4) | 4 of 4 |
| Malcolm Jan | Director | Jul 10, 2026 | open-market sale | 450 | — | $373K (9) | 9 of 9 |
| Mesa Nilda | Director | Sep 14, 2026 | option exercise | 6,560 | — | $356K (4) | 0 of 4 |
| Giltner Richard | Director | Jul 9, 2026 | option exercise | 21,884 | — | — | — |
| Dwek Raymond | Director | Apr 21, 2025 | open-market sale | 1,750 | — | — | — |
Questions
Are United Therapeutics Corp insiders buying or selling?
Over the twelve months to November 1, 2026, 12 insiders at United Therapeutics Corp sold $1.5B of stock in the open market, all by officers and directors, and 1 insider bought $864K, all by officers and directors. Net, insiders sold $1.5B. Only open-market purchases and sales are counted.
Who sold the most United Therapeutics Corp stock in the last year?
Rothblatt Martine A (Chairperson & CEO, Director) sold $944M in 2075 open-market sales over the twelve months to November 1, 2026.
Do United Therapeutics Corp executives sell under 10b5-1 plans?
2829 of the 2842 open-market sales in the last twelve months (100%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on United Therapeutics Corp
- United Therapeutics Corp financial statements
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.